Skip to main content


Figure 1 | BMC Research Notes

Figure 1

From: Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

Figure 1

Association of plasma interleukin (IL)-10 and regulated upon activation normal T cell expressed and secreted (RANTES) levels with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) toxicity. (a) Plasma RANTES levels at diagnosis show significant correlation with the severity of general fatigue (P = .025). (b) Percent decrease change of IL-10 was associated with severity of rash (P = .037).

Back to article page